We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+31.11%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.29B
AUM Growth
+$954M
Cap. Flow
+$337M
Cap. Flow %
10.25%
Top 10 Hldgs %
20.49%
Holding
135
New
9
Increased
113
Reduced
10
Closed
3

Sector Composition

Rank Sector Weight
1 Industrials 19.71%
2 Technology 16.05%
3 Healthcare 15.69%
4 Financials 12.98%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KN icon
26
Knowles
KN
$3.13B
$41M 1.25%
2,685,652
+285,292
+12% +$4.25M
IWM icon
27
iShares Russell 2000 ETF
IWM
$80.2B
$40.3M 1.23%
281,641
+10,719
+4% +$1.41M
NOVT icon
28
Novanta
NOVT
$5.03B
$39.8M 1.21%
372,345
+41,002
+12% +$3.81M
MODV
29
DELISTED
ModivCare
MODV
$38.5M 1.17%
487,369
+56,804
+13% +$3.84M
SLGN icon
30
Silgan Holdings
SLGN
$4.3B
$38.4M 1.17%
1,185,056
+65,149
+6% +$2.12M
DY icon
31
Dycom Industries
DY
$12.1B
$37.6M 1.14%
919,169
+110,297
+14% +$3.81M
ACHC icon
32
Acadia Healthcare
ACHC
$2.65B
$36.6M 1.11%
1,457,387
+137,345
+10% +$3.43M
AER icon
33
AerCap
AER
$23.7B
$36.5M 1.11%
1,184,969
+112,509
+10% +$3.22M
EEFT icon
34
Euronet Worldwide
EEFT
$2.83B
$35.6M 1.08%
371,322
+41,218
+12% +$3.81M
STAG icon
35
STAG Industrial
STAG
$7.42B
$35.5M 1.08%
1,209,587
+244,144
+25% +$6.43M
NVRI icon
36
Enviri
NVRI
$632M
$35.4M 1.08%
2,620,418
+580,090
+28% +$5.83M
SLRC icon
37
SLR Investment Corp
SLRC
$701M
$32.3M 0.98%
2,018,309
+177,491
+10% +$2.7M
CWST icon
38
Casella Waste Systems
CWST
$5.63B
$31.4M 0.95%
601,555
+67,815
+13% +$3.24M
BDC icon
39
Belden
BDC
$4.67B
$30.9M 0.94%
948,077
+105,159
+12% +$3.5M
THS
40
DELISTED
Treehouse Foods
THS
$28.4M 0.86%
648,630
+172,901
+36% +$8.44M
UTL icon
41
Unitil
UTL
$977M
$28.4M 0.86%
633,733
+72,724
+13% +$3.55M
AGI icon
42
Alamos Gold
AGI
$11.5B
$28.3M 0.86%
3,019,901
+254,346
+9% +$1.96M
CHCT
43
Community Healthcare Trust
CHCT
$530M
$27.8M 0.85%
680,217
+76,131
+13% +$2.85M
KRA
44
DELISTED
Kraton Corporation
KRA
$27.4M 0.83%
1,588,529
+298,822
+23% +$4.04M
CTLT
45
DELISTED
CATALENT, INC.
CTLT
$27.3M 0.83%
371,946
+35,467
+11% +$2.41M
TCF
46
DELISTED
TCF Financial Corporation Common Stock
TCF
$27.2M 0.82%
922,861
+79,385
+9% +$2.19M
SONO icon
47
Sonos
SONO
$1.73B
$26.8M 0.81%
1,832,957
+238,488
+15% +$2.53M
HASI icon
48
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.87B
$26.7M 0.81%
939,675
+211,287
+29% +$5.77M
WWE
49
DELISTED
World Wrestling Entertainment
WWE
$24.8M 0.75%
569,920
+62,198
+12% +$2.67M
SUPN icon
50
Supernus Pharmaceuticals
SUPN
$2.63B
$24.4M 0.74%
1,027,838
+287,199
+39% +$6.35M

Similar funds

Aristotle Capital Boston's Q2 2020 Portfolio in Review

As of Q2 2020, Aristotle Capital Boston held 135 positions worth $3.29B, up 41% from $2.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston deployed $337M of net new capital in Q2 2020, opening 9 new positions and adding to 113 existing holdings. Its largest new stake was Pacific Premier Bancorp: 2,156,731 shares worth $46.8M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was QuidelOrtho, an estimated $21.1M trimmed.

  • Aristotle Capital Boston's largest Q2 2020 buy was Pacific Premier Bancorp: 2,156,731 shares worth $46.8M.
  • Aristotle Capital Boston added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $9.3M increase.
  • Aristotle Capital Boston's biggest Q2 2020 reduction was QuidelOrtho, cutting an estimated $21.1M.
  • Aristotle Capital Boston fully exited Opus Bank Common Stock in Q2 2020, selling an estimated $37.9M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $3.29B portfolio in Q2 2020.
  • Aristotle Capital Boston opened 9 new positions and closed 3 in Q2 2020.
  • Aristotle Capital Boston's portfolio value rose 41% quarter-over-quarter to $3.29B.

Based on Aristotle Capital Boston's 13F filing for Q2 2020, filed 14 Aug 2020.